Clinical Trial Update: Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluates neoadjuvant chemoradiotherapy with or without concurrent azeliragon in newly diagnosed glioblastoma. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Azeliragon (Azeliragon)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioblastoma | EARLY_Phase 1 | Status: RECRUITING